PRL Share Price

Open 0.24 Change Price %
High 0.27 1 Day 0.02 8.33
Low 0.24 1 Week 0.02 8.33
Close 0.26 1 Month 0.05 23.81
Volume 1592768 1 Year -0.12 -31.58
52 Week High 0.41
52 Week Low 0.16
PRL Important Levels
Resistance 2 0.29
Resistance 1 0.28
Pivot 0.26
Support 1 0.24
Support 2 0.23
BIT Italy Most Active Stocks
ISP 2.53 -0.39%
PMI 0.36 0.00%
PMI 0.36 0.00%
SPM 0.40 0.00%
SPM 0.40 0.00%
TIT 0.84 1.20%
F 6.94 -2.12%
F 6.94 -2.12%
F 6.94 -2.12%
F 6.94 -2.12%
More..
BIT Italy Top Gainers Stocks
STEF 0.25 31.58%
ECA 0.06 20.00%
ECA 0.06 20.00%
ECA 0.06 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
PGR 300.00 20.00%
RIC 0.25 13.64%
RIC 0.25 13.64%
More..
BIT Italy Top Losers Stocks
S24 0.64 -8.57%
S24 0.64 -8.57%
S24 0.64 -8.57%
ROS 1.29 -7.19%
ROS 1.29 -7.19%
BCM 0.17 -5.56%
BCM 0.17 -5.56%
CIA 0.19 -5.00%
CIA 0.19 -5.00%
CIA 0.19 -5.00%
More..

Pierrel (BIT: PRL)

PRL Technical Analysis 4
As on 27th Mar 2017 PRL Share Price closed @ 0.26 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.25 & Strong Buy for SHORT-TERM with Stoploss of 0.23 we also expect STOCK to react on Following IMPORTANT LEVELS.
PRL Target for March
1st Target up-side 0.25
2nd Target up-side 0.27
3rd Target up-side 0.3
1st Target down-side 0.17
2nd Target down-side 0.15
3rd Target down-side 0.12
PRL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pierrel.it
PRL Address
PRL
Via Palestro, 6
Milan, MI 20121
Italy
PRL Latest News
Global Virus Network (GVN) Announces Seven Distinguished International ...   Digital Journal   - 22nd Mar 17
Newron Supports Global Rare Disease Day® 2017 and Rett Syndrome Studies   PharmiWeb.com (press release)   - 21st Feb 17
VBL Therapeutics Reports Full Data for VB-111 Monotherapy in Phase 2 Trial for ...   PharmiWeb.com (press release)   - 21st Feb 17
Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term ...   PharmiWeb.com (press release)   - 17th Feb 17
TRACON Pharmaceuticals Announces First Patient Dosed in Phase 3 TAPPAS Trial ...   PharmiWeb.com (press release)   - 16th Feb 17
Mammoth Food & Wine   The Sheet   - 04th Jul 15
Mammoth Mountain Downhill Adventures   Diablo Magazine (blog)   - 05th Mar 15
QUICK PICS: Check Out The Hottest Celeb Pics This Week   OK! Magazine   - 03rd Mar 15
Pierrel Research USA Launches Orabloc™ a New Purer Articaine   PR Newswire (press release)   - 11th May 11
Cookies on Pharmiweb.Com   PharmiWeb.com (press release)   - 04th Jun 05
Interactive Technical Analysis Chart Pierrel ( PRL BIT Italy )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pierrel
PRL Business Profile
Pierrel S.p.A. provides contract research and manufacturing services to the pharmaceutical and life science industries. It primarily manufactures local dental anesthetic drug cartridges. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations. It also provides consulting and operational services for the research and development of new molecules and drug products; and consulting services for clinical and regulatory development programs, as well as operational services for the execution of international phase I-IV, late phase, and non-interventional clinical trials. The company operates in the United States, Australia, Canada, Russia, and the Middle East. Pierrel S.p.A. is based in Milan, Italy.